에너지식 미용 기기 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Energy-based Aesthetic Devices Market Summary

The global energy-based aesthetic devices market size was estimated at USD 7.52 billion in 2025 and is projected to reach USD 15.77 billion by 2033, growing at a CAGR of 9.8% from 2026 to 2033. The rising prevalence of skin conditions such as dryness, acne, and fungal infections majorly drives the market growth.

Moreover, ongoing technological advancements in aesthetic devices have further strengthened market development. Advancements in energy-based aesthetic devices are driving the market growth. According to the Aesthetic Guide article published in October 2023, Micro-Coring is an innovative technique gaining popularity for enhancing skin texture and tightening areas prone to laxity, such as the lower face & jowls.

This non-invasive method removes tiny tissue cores to stimulate skin rejuvenation and tightening. The significance of Micro-Coring lies in its ability to offer substantial improvements in skin quality with minimal downtime, making it an appealing option for patients seeking effective aesthetic treatments without resorting to invasive surgery.

In May 2025, Laser and Health Academy (LA&HA), in collaboration with Fotona and Zaneo / Odella, opened two new training centers in Latin America: the LA&HA Colombia Training Center in Bogota and the LA&HA Mexico Training Center in Mexico City. This is expected to further expand the academy's global footprint in medical laser education. Both new centers are expected to offer specialized workshops in gynecology and aesthetics, supported by experienced LA&HA faculty and local doctors.

A growing population of appearance-conscious individuals drives the demand for energy-based aesthetic devices. The market's expansion is further reinforced by greater access to aesthetic procedures, a rising global incidence of obesity, heightened awareness of medical aesthetic treatments, and continual technological innovation in device design and functionality. Moreover, social media's influence has been pivotal in shaping aesthetic preferences and promoting awareness of various energy-based treatment options. These factors encourage more individuals worldwide to pursue youthful and revitalized appearances.

The rising prevalence of obesity is driving the demand for effective treatment options, including energy-based aesthetic devices. As more individuals seek solutions to manage and reduce obesity-related concerns, the market for noninvasive treatments is expanding. Energy-based aesthetic devices offer innovative body contouring and weight management approaches, positioning them as crucial in addressing the growing global obesity epidemic. According to a WHO article published in March 2024, obesity has become a significant global health concern, with 1 in 8 people worldwide affected by this condition in 2022. The rate of adult obesity has more than doubled since 1990, while adolescent obesity has increased fourfold. In particular, 2.5 billion adults are now categorized as overweight, with 890 million living with obesity. In addition, 43% of adults aged 18 & over were overweight, and 16% were affected by obesity. Among children, 37 million under the age of 5 and over 390 million aged 5-19 were overweight, with 160 million of the latter group being obese.

Global Energy-based Aesthetic Devices Market Report Segmentation

This report forecasts revenue growth at global levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global energy-based aesthetic devices market report based on product, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Medical Laser-Based Devices
• Light-Based Devices
• Radiofrequency (RF) Based Devices
• Ultrasound
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Body Contouring
• Skin Tightening
• Skin Rejuvenation
  • Wrinkles
  • Acne & Other Scars
  • Skin Pigmentation
  • Aging
• Hair Removal
• Leg Vein Treatment
• Vaginal Rejuvenation
• Pigmented Lesion
• Tattoo Removal
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospital/Surgery Center
• Medspa
• Traditional Spa
• HCP Owned Clinic
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Sweden
  • Denmark
  • Norway
  • Netherlands
  • Switzerland
  • Austria
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Singapore
  • Malaysia
  • Indonesia
• Latin America
  • Brazil
  • Argentina
  • Chile
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Jordan
  • Qatar
  • Morocco

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Energy-based Aesthetic Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Energy-based Aesthetic Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Energy-based Aesthetic Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Energy-based Aesthetic Devices Market: Product Movement Analysis
• 4.3. Energy-based Aesthetic Devices Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Medical Laser-Based Devices
  • 4.5.1. Medical Laser-Based Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Light-Based Devices
  • 4.6.1. Light-Based Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Radiofrequency (RF) Based Devices
  • 4.7.1. Radiofrequency (RF) Based Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Ultrasound
  • 4.8.1. Ultrasound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Energy-based Aesthetic Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Energy-based Aesthetic Devices Market: Application Movement Analysis
• 5.3. Energy-based Aesthetic Devices Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Body Contouring
  • 5.5.1. Body Contouring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Skin Tightening
  • 5.6.1. Skin Tightening Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Skin Rejuvenation
  • 5.7.1. Skin Rejuvenation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.2. Wrinkles
    • 5.7.2.1. Wrinkles Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.3. Acne & Other Scars
    • 5.7.3.1. Acne & Other Scars Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.4. Skin Pigmentation
    • 5.7.4.1. Skin Pigmentation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7.5. Aging
    • 5.7.5.1. Aging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Hair Removal
  • 5.8.1. Hair Removal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Leg Vein Treatment
  • 5.9.1. Leg Vein Treatment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Vaginal Rejuvenation
  • 5.10.1. Vaginal Rejuvenation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.11. Pigmented Lesion
  • 5.11.1. Pigmented Lesion Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.12. Tattoo Removal
  • 5.12.1. Tattoo Removal Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.13. Others
  • 5.13.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Energy-based Aesthetic Devices Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Energy-based Aesthetic Devices Market: End Use Movement Analysis
• 6.3. Energy-based Aesthetic Devices Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospital/Surgery Center
  • 6.5.1. Hospital/Surgery Center Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Medspa
  • 6.6.1. Medspa Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Traditional Spa
  • 6.7.1. Traditional Spa Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. HCP Owned Clinic
  • 6.8.1. HCP Owned Clinic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Energy-based Aesthetic Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Energy-based Aesthetic Devices Market Movement Analysis
• 7.3. Energy-based Aesthetic Devices Market: Regional Estimates & Trend Analysis by Modality & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Regulatory framework/ reimbursement structure
    • 7.6.4.3. Competitive scenario
    • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Regulatory framework/ reimbursement structure
    • 7.6.5.3. Competitive scenario
    • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.6. Denmark
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Regulatory framework/ reimbursement structure
    • 7.6.6.3. Competitive scenario
    • 7.6.6.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Regulatory framework/ reimbursement structure
    • 7.6.7.3. Competitive scenario
    • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.8. Norway
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Regulatory framework/ reimbursement structure
    • 7.6.8.3. Competitive scenario
    • 7.6.8.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.9. Switzerland
    • 7.6.9.1. Key country dynamics
    • 7.6.9.2. Regulatory framework/ reimbursement structure
    • 7.6.9.3. Competitive scenario
    • 7.6.9.4. Switzerland market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.10. Austria
    • 7.6.10.1. Key country dynamics
    • 7.6.10.2. Regulatory framework/ reimbursement structure
    • 7.6.10.3. Competitive scenario
    • 7.6.10.4. Austria market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6.11. Netherlands
    • 7.6.11.1. Key country dynamics
    • 7.6.11.2. Regulatory framework/ reimbursement structure
    • 7.6.11.3. Competitive scenario
    • 7.6.11.4. Netherlands market estimates and forecasts 2021 to 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Regulatory framework/ reimbursement structure
    • 7.7.5.3. Competitive scenario
    • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Regulatory framework/ reimbursement structure
    • 7.7.6.3. Competitive scenario
    • 7.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.7. Singapore
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Regulatory framework/ reimbursement structure
    • 7.7.7.3. Competitive scenario
    • 7.7.7.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.8. Malaysia
    • 7.7.8.1. Key country dynamics
    • 7.7.8.2. Regulatory framework/ reimbursement structure
    • 7.7.8.3. Competitive scenario
    • 7.7.8.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7.9. Indonesia
    • 7.7.9.1. Key country dynamics
    • 7.7.9.2. Regulatory framework/ reimbursement structure
    • 7.7.9.3. Competitive scenario
    • 7.7.9.4. Indonesia market estimates and forecasts 2021 to 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Regulatory framework/ reimbursement structure
    • 7.8.1.3. Competitive scenario
    • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Regulatory framework/ reimbursement structure
    • 7.8.2.3. Competitive scenario
    • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8.3. Chile
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Regulatory framework/ reimbursement structure
    • 7.8.3.3. Competitive scenario
    • 7.8.3.4. Chile market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8.4. Colombia
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Regulatory framework/ reimbursement structure
    • 7.8.4.3. Competitive scenario
    • 7.8.4.4. Colombia market estimates and forecasts 2021 to 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Regulatory framework/ reimbursement structure
    • 7.9.1.3. Competitive scenario
    • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Regulatory framework/ reimbursement structure
    • 7.9.2.3. Competitive scenario
    • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Regulatory framework/ reimbursement structure
    • 7.9.3.3. Competitive scenario
    • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Regulatory framework/ reimbursement structure
    • 7.9.4.3. Competitive scenario
    • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.5. Qatar
    • 7.9.5.1. Key country dynamics
    • 7.9.5.2. Regulatory framework/ reimbursement structure
    • 7.9.5.3. Competitive scenario
    • 7.9.5.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.6. Morocco
    • 7.9.6.1. Key country dynamics
    • 7.9.6.2. Regulatory framework/ reimbursement structure
    • 7.9.6.3. Competitive scenario
    • 7.9.6.4. Morocco market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9.7. Jordan
    • 7.9.7.1. Key country dynamics
    • 7.9.7.2. Regulatory framework/ reimbursement structure
    • 7.9.7.3. Competitive scenario
    • 7.9.7.4. Jordan market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Syneron Medical Ltd
    • 8.2.1.1. Company Overview
    • 8.2.1.2. Financial Performance
    • 8.2.1.3. Product Benchmarking
    • 8.2.1.4. Strategic Initiatives
  • 8.2.2. Sinclair
    • 8.2.2.1. Company Overview
    • 8.2.2.2. Financial Performance
    • 8.2.2.3. Product Benchmarking
    • 8.2.2.4. Strategic Initiatives
  • 8.2.3. Acclaro Medical
    • 8.2.3.1. Company Overview
    • 8.2.3.2. Financial Performance
    • 8.2.3.3. Product Benchmarking
    • 8.2.3.4. Strategic Initiatives
  • 8.2.4. Candela Corporation
    • 8.2.4.1. Company Overview
    • 8.2.4.2. Financial Performance
    • 8.2.4.3. Product Benchmarking
    • 8.2.4.4. Strategic Initiatives
  • 8.2.5. Lumenis
    • 8.2.5.1. Company Overview
    • 8.2.5.2. Financial Performance
    • 8.2.5.3. Product Benchmarking
    • 8.2.5.4. Strategic Initiatives
  • 8.2.6. El.En. S.p.A.
    • 8.2.6.1. Company Overview
    • 8.2.6.2. Financial Performance
    • 8.2.6.3. Product Benchmarking
    • 8.2.6.4. Strategic Initiatives
  • 8.2.7. Cutera, Inc.
    • 8.2.7.1. Company Overview
    • 8.2.7.2. Financial Performance
    • 8.2.7.3. Product Benchmarking
    • 8.2.7.4. Strategic Initiatives
  • 8.2.8. Alma Lasers.
    • 8.2.8.1. Company Overview
    • 8.2.8.2. Financial Performance
    • 8.2.8.3. Product Benchmarking
    • 8.2.8.4. Strategic Initiatives
  • 8.2.9. Cynosure
    • 8.2.9.1. Company Overview
    • 8.2.9.2. Financial Performance
    • 8.2.9.3. Product Benchmarking
    • 8.2.9.4. Strategic Initiatives
  • 8.2.10. Fotona
    • 8.2.10.1. Company Overview
    • 8.2.10.2. Financial Performance
    • 8.2.10.3. Product Benchmarking
    • 8.2.10.4. Strategic Initiatives
  • 8.2.11. Solta Medical
    • 8.2.11.1. Company Overview
    • 8.2.11.2. Financial Performance
    • 8.2.11.3. Product Benchmarking
    • 8.2.11.4. Strategic Initiatives